BR112022003517A2 - Método de capeamento de rna enzimático - Google Patents

Método de capeamento de rna enzimático

Info

Publication number
BR112022003517A2
BR112022003517A2 BR112022003517A BR112022003517A BR112022003517A2 BR 112022003517 A2 BR112022003517 A2 BR 112022003517A2 BR 112022003517 A BR112022003517 A BR 112022003517A BR 112022003517 A BR112022003517 A BR 112022003517A BR 112022003517 A2 BR112022003517 A2 BR 112022003517A2
Authority
BR
Brazil
Prior art keywords
capating
capping
enzymatic rna
rna
variant
Prior art date
Application number
BR112022003517A
Other languages
English (en)
Portuguese (pt)
Inventor
Brett Robb G
Chan Siu-Hong
Roy Bijoyita
Original Assignee
New England Biolabs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Biolabs Inc filed Critical New England Biolabs Inc
Priority claimed from PCT/US2020/047533 external-priority patent/WO2021041267A1/en
Publication of BR112022003517A2 publication Critical patent/BR112022003517A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1003Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007Methyltransferases (general) (2.1.1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1077Pentosyltransferases (2.4.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y201/00Transferases transferring one-carbon groups (2.1)
    • C12Y201/01Methyltransferases (2.1.1)
    • C12Y201/01056Methyltransferases (2.1.1) mRNA (guanine-N7-)-methyltransferase (2.1.1.56)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/02Pentosyltransferases (2.4.2)
    • C12Y204/02003Uridine phosphorylase (2.4.2.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07045Guanosine-triphosphate guanylyltransferase (2.7.7.45)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR112022003517A 2019-08-23 2020-08-21 Método de capeamento de rna enzimático BR112022003517A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962890821P 2019-08-23 2019-08-23
PCT/US2020/047533 WO2021041267A1 (en) 2019-08-23 2020-08-21 Enzymatic rna capping method
PCT/US2020/047521 WO2021041260A1 (en) 2019-08-23 2020-08-21 Enzymatic rna capping method

Publications (1)

Publication Number Publication Date
BR112022003517A2 true BR112022003517A2 (pt) 2022-07-19

Family

ID=80856181

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022003517A BR112022003517A2 (pt) 2019-08-23 2020-08-21 Método de capeamento de rna enzimático

Country Status (5)

Country Link
US (5) US12479880B2 (https=)
JP (2) JP7749539B2 (https=)
KR (1) KR20220046693A (https=)
AU (1) AU2020336278A1 (https=)
BR (1) BR112022003517A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7749539B2 (ja) * 2019-08-23 2025-10-06 ニユー・イングランド・バイオレイブス・インコーポレイテツド 酵素的rnaキャッピング法
KR20230148714A (ko) 2022-04-18 2023-10-25 에스케이바이오사이언스(주) 면역원성 조성물 및 이의 제조방법
WO2025164636A1 (ja) * 2024-01-30 2025-08-07 タカラバイオ株式会社 ファウストウイルスs17株由来のrnaキャッピング酵素
WO2025263589A1 (ja) * 2024-06-20 2025-12-26 ヤマサ醤油株式会社 Rnaの5'末端から1番目及び2番目のヌクレオチドにおけるリボースの水酸基をメチル化するためのメチル基転移酵素、メチル化方法、メチル基転移酵素の使用、及びキット

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2010659B1 (en) 2006-04-14 2014-06-18 CellScript, Inc. Kits and methods for generating 5' capped RNA
EP2377938A1 (en) 2010-04-16 2011-10-19 Eukarys Capping-prone RNA polymerase enzymes and their applications
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
WO2014028429A2 (en) 2012-08-14 2014-02-20 Moderna Therapeutics, Inc. Enzymes and polymerases for the synthesis of rna
KR101422936B1 (ko) 2012-11-30 2014-07-23 삼성전기주식회사 모터 구동 제어 장치, 모터 구동 제어 방법 및 그를 이용한 모터
ES3032935T3 (en) 2013-10-22 2025-07-29 Translate Bio Inc Lipid formulations for delivery of messenger rna
EP3077406B1 (en) 2013-12-05 2019-07-10 New England Biolabs, Inc. Compositions and methods for capping rna
US11479766B2 (en) 2013-12-05 2022-10-25 New England Biolabs, Inc. Methods for labeling a population of RNA molecules
US10428368B2 (en) * 2013-12-05 2019-10-01 New England Biolabs, Inc. Methods for enriching for a population of RNA molecules
BR112016030852A2 (pt) 2014-07-02 2018-01-16 Shire Human Genetic Therapies encapsulação de rna mensageiro
EP3303575B1 (en) * 2015-05-29 2022-03-16 CureVac AG Method for adding cap structures to rna using immobilized enzymes
CN116144626A (zh) 2016-01-13 2023-05-23 新英格兰生物实验室公司 T7 rna聚合酶的热稳定变体
US10034951B1 (en) 2017-06-21 2018-07-31 New England Biolabs, Inc. Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity
CN111164207A (zh) * 2017-07-27 2020-05-15 优卡瑞斯 新型嵌合酶及其应用
US12398173B2 (en) * 2019-08-23 2025-08-26 New England Biolabs, Inc. Enzymatic RNA capping method
JP7749539B2 (ja) * 2019-08-23 2025-10-06 ニユー・イングランド・バイオレイブス・インコーポレイテツド 酵素的rnaキャッピング法
US11788074B2 (en) 2020-06-23 2023-10-17 New England Biolabs, Inc. Vaccinia capping enzyme compositions and methods

Also Published As

Publication number Publication date
JP2026001059A (ja) 2026-01-06
JP2022544712A (ja) 2022-10-20
CA3147797A1 (en) 2021-03-04
US20250388618A1 (en) 2025-12-25
JP7749539B2 (ja) 2025-10-06
US12479880B2 (en) 2025-11-25
US20260062438A1 (en) 2026-03-05
AU2020336278A1 (en) 2022-04-07
US20240383939A1 (en) 2024-11-21
US20260062439A1 (en) 2026-03-05
US20260015379A1 (en) 2026-01-15
KR20220046693A (ko) 2022-04-14

Similar Documents

Publication Publication Date Title
BR112022003517A2 (pt) Método de capeamento de rna enzimático
JP7437474B2 (ja) 標的rnaを検出するための方法及び組成物
US20210332078A1 (en) Compositions and methods for nucleic acid amplification
Gray Evolutionary origin of RNA editing
ATE489473T1 (de) Analyse von boten-rna und mikro-rna im gleichen reaktionsansatz
ES2386023T3 (es) Método mejorado para la prevención de la contaminación cruzada en tecnologías de amplificación de ácidos nucleicos
MY204767A (en) Polymerases, compositions, and methods of use
KR20200111180A (ko) Crispr 이펙터 시스템 기반 다중 진단
GB2578844A (en) Methods for seamless nucleic acid assembly
CA3049961A1 (en) Crispr effector system based diagnostics
BRPI0706947B8 (pt) método de preparação de uma composição de micropartícula
Veal et al. A mechanistic basis for amplification differences between samples and between genome regions
BRPI0809696A8 (pt) Catalisador de base biológica para retardar processos de desenvolvimento de plantas
BR112023026862A2 (pt) Compostos de oligonucleotídeos anti-flt1 otimizados para tratamento de pré-eclâmpsia e outros distúrbios angiogênicos
CN111183229A (zh) 使用有限核苷酸组成的引物的数字扩增
BR112017025785A2 (pt) ?biossensor, enzima de glicose desidrogenase, enzima oxirredutase, polipeptídeo, composição ou kit, método de detecção de uma molécula alvo, método de diagnóstico de uma doença ou condição em um organismo, dispositivo de detecção, ácido nucleico isolado, construção gênica, célula hospedeira e método para produzir um biossensor?
WO2006040187A3 (en) A method for the carry-over protection in dna amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids
BR112014014307A2 (pt) métodos e kits para detecção in situ à temperatura ambiente de um ácido nucleico alvo em uma amostra biológica
WO2023039005A3 (en) Modified short interfering nucleic acid (sina) molecules and uses thereof
MX386601B (es) Disminución de homocisteína mediada por enzimas humanas para el tratamiento de pacientes con hiperhomocisteinemia y homocistinuria.
Smith et al. A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents
LT2017523A (lt) N4-modifikuoti citidino nukleotidai ir jų panaudojimas
BR112017008026A2 (pt) processos de produção de composições com melhor perfil de segurança que possui atividade de lipase e composições apropriadas para uso farmacêutico
BR112022001539A2 (pt) Captura e análise de regiões genômicas alvo
BR112016029564A2 (pt) composição ativa em condições ambiente para remoção de manchas de substratos manchados, dispositivo de pré- tratamento, processo para remover uma mancha de um substrato manchado e uso de um composto de éster alquílico de arginina